In this Consumer Update video, FDA Product Safety Expert Deborah Autor, J.D., helps explain the agency's warning to stop using body building products that claim to contain steroids or steroid-like substances.
More information can be found on:
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm173739.htm
Organised Crime and Drugs in Sport : New Generation Performance and Image Enhancing Drugs and Organised Criminal Involvement in their use in Professional Sport / Australian Crime Commission (ACC). - Canberra City : ACC, 2013
Contents:
- LIMITATIONS ON DISCLOSURE OF FINDINGS
- KEY FINDINGS
- PERFORMANCE AND IMAGE ENHANCING SUBSTANCES
- PEPTIDE AND HORMONE CONSUMERS
- SOURCES OF PEPTIDES AND HORMONES
- ORGANISED CRIME, DRUGS AND SPORT
- VULNERABILITIES TO INTEGRITY MECHANISMS
In 2011, the Australian Crime Commission (ACC) highlighted threats to the integrity of professional sport and concluded that there was potential for organised crime to infiltrate sport in Australia, as has occurred overseas.
Data from the ACC’s 2010–11 Illicit Drug Data Report indicated that the market for Performance and Image Enhancing Drugs (PIEDs) has expanded, with record numbers of seizures, detections and arrests and increasing reports by users that they were injecting them. The ACC also received information from the Australian Sports Anti-Doping Authority (ASADA), as part of the ACC’s routine monitoring of all illicit drug markets, which suggested a potential threat to a number of sports from the use of new generation PIEDs.
In early 2012, the ACC, with the assistance of ASADA, began a project to consider the extent of use of PIEDs by professional athletes, the size of this market and the extent of organised criminal involvement. This project focused particularly on a new form of PIEDs,
known collectively as peptides and hormones. These substances may provide effects similar to anabolic steroids and are considered by users to be next generation PIEDs. Some of these substances are perceived by athletes to be undetectable, making them attractive to those seeking to gain an unfair advantage.
This report provides a summary of findings from this project. In particular, the ACC has now identified use of these substances, which are prohibited by the World Anti-Doping Agency (WADA), by professional athletes in a number of sports in Australia. Widespread use has been identified or is suspected in a number of professional sporting codes.
In detailing the nature and extent of this threat to the professional sporting industry and the Australian Community, this report provides an important opportunity for Government, regulatory bodies and the sporting industry to address these issues head on.
Risicogedrag bij het online bestellen van geneesmiddelen (Dutch title)
Intomart GfK has, by order of the Dutch Ministry of Health, Welfare and Sport, conducted a quantitative research in early 2009, and a second wave in October 2012.
The aim of the re-search is to gain insight in the target group of people who have purchased medication on-line or who consider doing so (‘considerers’). This research provides insights in the background details of on-line purchasers and developments in their motives, behavior, risk perception and need for information.
Profile people purchasing and considering on-line purchase 13% of the of the adults (18+) indicate, in Autumn 2012, ever having purchased medication on-line. A further 6% of the adults have at some point in time considered purchasing medication on-line.
On-line medication is often purchased without a doctor’s prescription. The percentage of Dutchmen that have purchased medication on-line without a prescription at some point in their lives increased from 3% in 2009 to 11% in 2012. Dutchmen who do not purchase medication on-line are, on average, older and tend to have a slightly lower level of education than those who do. Female consumers buy medication on-line slightly more often than male consumers.
The prime motive for purchasing medication on-line is convenience; the possibility to order out-side office hours and home delivery are considered great advantages. The motives for not buying medication on-line are widely divergent, but mostly concern lack of clarity of the information.
Purchase behavior
On-line medication is often purchased without a doctor’s prescription (ranging from 30% for antibiotics to 96% for diet pills). Usually people do not consult their doctor when considering the on-line purchase of medication. However, people do have a need for information, and they often look for it on the internet.
Although more and more Dutchmen order medication on-line, the frequency of the purchases has decreased. Medication is bought on-line rather occasionally. For ordering medication, people usually go to Dutch websites. Customer satisfaction with the medication ordered is high, as is the willingness to promote the on-line purchase of medication to others; over half of the customers (55%) would recommend others to buy their medication on-line. This especially holds true for contraceptives and painkillers.
Satisfaction with on-line purchase is lowest for hypnotic medication, anti-smoking medication and diet pills. The most common reasons for dissatisfaction are the lack of improvement of sleep, failure to quit smoking or insufficient weight loss.
Risk perception
People who have purchased medication on-line and considerers are to a large degree aware of the risks involved. Two in three buyers and considerers acknowledge that control by a pharmacist’s may be lacking, and the composition of a product may be different. More than half of the customers know that the Patient Information Leaflet (PIL) may be missing or is unclear, or that the product has the wrong label.
Even though buyers and considerers are equally aware of the different risk factors associated with the on-line purchase of medication, there is a difference between these two groups in the perception of the magnitiude of the risks these pose for one’s health. For example, buyers estimate the risk of on-line medication being falsified at 28%, whereas considerers estimate this risk at 52%.
Buyers are aware of the risks but think they can manage them, and therefore they purchase their medication on-line. Considerers are more cautious. The greatest perceived risk is the lack of checks on possible side effects due to interactions with other medication. However, the other risk factors are estimated as being at an almost equally high level. The risks of side effects due to interactions can be brought to the attention of people currently already using other medications. For people currently not using any medications, this message will have no deterrent effect whatsoever.
Need for information
Considerers often have a higher demand for information than buyers (buyers: 31%, considerers: 43%). The need for information has, in 2012, increased somewhat since the previous wave of 2009. On-line buyers of medication who seek information about ordering medication on-line safely, mostly declare to do so via their regular pharmacy. The primary source of information to considerer is the internet. The Dutch Ministry of Health uses the website internetpillen.nl, along with other sources, to provide buyers and considerers with information about, for example, how to identify suppliers of counterfeit medication and how to order medication on-line safely. The website is mostly unknown, with only 3% awareness amongst buyers and 2% amongst considerers. The target audience either does not find its way to, or does not remember, the website.
Opinions vary widely about which would be the most obvious source of information about safely purchasing medication on-line. There are several credible parties that could provide the information. Buyers seem to have a slight preference for their regular pharmacy, while considerers prefer the general practitioner. Both groups also name the Ministry of Health and the RIVM (the National Institute of Public Health and Environment of the Netherlands) as obvious providers of the information.
Conclusions
More and more Dutchmen order their medication on-line, often without consulting a physician. To a large degree they are satisfied with the delivered product, and recommend it to others. In light of the high degree of satisfaction among a large group of Dutchmen, it can be expected that the on-line purchase of medication will increase further, and will even become widely accepted, in the years to come.
Even though on-line buyers of medication are aware of the risks involved with the on-line purchase of medication, they are confident that they are capable of assessing a provider’s trustwor-thiness. The lack of any check on possible side effects due to interactions with other medication is considered the greatest risk. The risks of side effects due to interactions can be brought to the attention of people currently already using other medications. Buyers see their regular pharmacy as an obvious and reliable source of information, making it the logical choice as a provider of information about the risk of purchasing medication on-line.
WADA - Play True Magazine
2011, issue 1
Tried, Tested and True - Profiling the Global Network of WADA Accredited Anti-Doping Laboratories
----------------------------------------------------------------------------------
Content
Editorials
01 Editorial John Fahey: Objectives for a New Mandate
02 Editorial David Howman: Maximizing Results
Cover Story
03 Anti-Doping Laboratories
05 The Accreditation Process
06 Quality Assessment (EQAS)
07 Map of WADA Accredited Laboratories
09 The New Concept of Approved Laboratories
10 Interview with Dr Günter Gmeiner
11 The importance of Research
Features
12 Code Compliance
13 Social Science Symposium
15 Athlete Profile: Daichi Suzuki
17 Revamped Outreach Model
19 New Anti-Doping Resources
WADA Updates
20 Fahey to Remain President
20 2013 World Conference
20 Staff Updates
21 CoachTrue Awards
21 UNESCO Convention
WADA - Play True Magazine
2011, issue 2
Widening the Net - How improved data-sharing with state and global law enforcement agencies is leading to more effective investigations into banned substances
----------------------------------------------------------------------------------
Content
Editorials
01 Editorial John Fahey: Creating partnerships and developing cooperation
02 Editorial David Howman: 'Awareness' crucial in the fight against doping in sport
Cover story
03 Harnessing law enforcement and information gathering
05 WCO signs on in support
Features
06 Athlete Profile: Cydonie Mothersill
09 Reaching out to Africa
09 Rosa Mota in Africa
10 WADA at Parapan am Games
10 WADA at Commonwealth Youth Games
15 Rome Symposium
17 2011 Young Investigator Award
WADA Updates
18 RADOs
19 UNESCO International Convention
WADA - Play True Magazine
2012, issue 1
The Code in Review - Moving ahead though stakeholder consultation and the Code Review Process
----------------------------------------------------------------------------------
Content
Editorials
01 Editorial John Fahey: Better Practice and a new way forward for WADA
02 Editorial David Howman: A period of adjustment as WADA adapts to new challenges and conditions
Cover Story
03 Code Review Process Underway
04 Code Collaboration
Features
09 WADA completes Compliance Report
10 South Africa hosts first of three education symposia
10 Play True Challenge wins award
10 Digital library for education tools
13 Interview: UKAD's Gabriella Re
15 New Athlete Committee Members
17 Athlete Profile: Katarzyna Rogowiec
19 Athlete Committee calls for more blood sampling and EPO testing
19 Japan and Russia to host Athlete Committee meetings
20 Educational tool kit for sport physicians
20 WADA addresses Family Physicians Conference
21 Outreach: Strong awareness focus in 2011
23 Say NO! To Doping
25 Enhanced electronic Play True
25 Japan to continue Asian RADO funding
WADA - Play True Magazine
2012, issue 2
London 2012 - WADA's role in London and the efforts of the world's anti-doping community to provide a clean Olympic and Paralympic Games
------------------------------------------------------------------------
Content
Messages
02 Editorial John Fahey: Responsibility lies with athletes to make London 2012 doping free
04 Editorial Jacques Rogge: We must never stop trying to eliminate doping in sport
Cover story
05 WADA at the 2012 Olympic and Paralympic Games
Features
10 WADA IO and Outreach in London
16 Working towards a clean Games
18 London 2012 Anti-Doping Laboratory: The road to accreditation
20 Anti-doping figures for London 2012
Athlete profile
22 Athlete Profile: David Millar
Features
25 Code Review Process
26 International experts shape anti-doping future at WADA symposium
27 WADA recognizes 20-year anniversary of CCES
27 Kuwait Conference focuses on further RADO development
28 JADA reaches 10-year milestone
29 Partnership conference for pharmaceutical industry and WADA
29 CHINADA completes ADAMS implementation
30 South African hosts sign World Conference agreement
WADA - Play True Magazine
2013, issue 1
Prevention though Education - Ensuring effective mechanisms of delivery for values-based messages
----------------------------------------------------------------------------------
Content
Messages
02 Editorial John Fahey: Nobody is above the rules of sport
04 Editorial David Howman: Code review makes testing more efficient and effective
Cover story
06 Increasing the role of education in prevention
Features
10 Prevention through education
12 Education tools
14 The spirit of sport and anti-doping policy: an ideal worth fighting for
17 Strengthening the World Anti-Doping Code
21 Paris Pharmaceutical Conference enhances cooperation
Athlete profile
22 Athlete Profile: Felipe Contepomi
News
23 Western Cape continues support for WADA
24 Play True Generation at South American School Games
25 Doping film wins documentary award
25 Say NO! to Doping at Floorball World Championships
26 SEA RADO benefits from DCO exchange
26 RADOs contribute to London 2012 anti-doping program and assist regional games
Facts
The Royal Netherlands Power Sport and Fitness Federation (Koninklijke Nederlandse Krachtsport en Fitnessfederatie, KNKF) has reported an anti doping rule violation against the athlete. The athlete had provided a sample for doping control purposes. Analysis of the sample showed the presence of a metabolite of metandienone and oxilofrine. Metandienone and oxilofrine are prohibited substances according the world Anti-Doping Agency (WADA) prohibited list.
History
The athlete claims a sudden diagnose for diabetics for which he used medication, this medication must be the cause for the positive test. He has a list from his general practitioner with the prescribed medications. However the panel concludes that, none of these medications contain these prohibited substances.
Decision
1. The sanction is a period of ineligibility of two years.
2. The administrative costs for the procedure will be borne by the athlete.
CAS 2008/A/1585 Yücel Kop v. International Association of Athletics Federations (IAAF) & Turkish Athletics Federation (TAF) and CAS 2008/A/1586 Süreyya Ayhan Kop v. IAAF & TAF
Related cases:
1. The purpose of article 13.2.1 of the WADA Code is not to exclude the possibility for anti-doping organizations to institute a review system below the CAS for decisions concerning international-level athletes but rather to ensure that CAS is the final body to which decisions concerning an international-level athletes may be appealed, thereby providing them with the same treatment under unified rules and practices that ultimately guarantee a more level playing field in international competitions, in the interest of fairness and equality of treatment.
2. An athlete who committed at least two standard sanctions, which under the applicable rules require an ineligibility sanction of between 8 years and a life ban, leaves no other option to a CAS panel than to find a life ban would apply under the 2009 IAAF Rules when both violations must be deemed very serious in nature, while at the same time no tangible elements of proof allow to consider that the athlete did not intentionally commit the violations in both instances. In this respect, there is no more need to establish whether the violations would formally qualify as being committed in aggravating circumstances under the 2009 IAAF Rules.
3. A CAS Panel has the authority to evaluate and decide the case de novo; and has therefore the power to vary a sanction in either direction provided that such variation has been duly requested by a party.
In 2004 multiple anti-doping rule violations were reported against the Athlete Süreyya Ayhan Kop. Consequently on 15 June 2005 the Athlete was sanctioned for 2 years.
Thereupon in October 2007 the IAAF reported an anti-doping rule violation against the Athlete after her out-of-competion sample tested positive for the prohibited substances Stanozolol and Metandienone.
As a result on 25 January 2008 - and again upholded on 2 April 2008 - the Turkish Athletics Federation (TAF) Disciplinary Commission decided to impose a lifetime period of ineligibility on the Athlete for her second anti-doping rule violation.
Following the Athlete's appeal the Turkish Youth and Sport Tribunal decided on 30 May 2008 to reduce the sanction to a four year period of ineligibility.
Hereafter in June 2008 the Athlete appealed the Turkish Tribunal decision of 30 May 2008 with the Court of Arbitration for Sport (CAS).
The athlete argued that the Appealed Decision wrongly ruled that she should be subject to a four-year ban. By contrast the IAAF contended that the Athlete committed a second anti-doping rule violation and must therefore be declared ineligible for life under the IAAF Rules.
Having examined the table of sanctions provided under Rule 40.7 and characterized the Athlete’s 2004 and 2007 violations the Panel finds that she, at the very least committed two standard sanctions, which under the rule require an ineligibility sanction of between 8 years and a life ban.
Moreover, based on the evidence on record there is no doubt that both violations must be deemed very serious in nature while at the same time no tangible elements of proof allow to consider that the Athlete did not intentionally commit the violations in both instances.
Consequently, the Panel has no other option than to find a life ban would apply under the 2009 IAAF Rules. For those reasons, the Panel need not address whether the violations would formally qualify as being committed in aggravating circumstances as defined under Rule 40.6 of the 2009 IAAF Rules.
Therefore the Court of Arbitration for Sport decides on 11 November 2009:
1.) The decision with reference numbers 2008/55 and 2008/10 issued on 30 May 2008 by the Arbitral Tribunal of the Turkish General Directorate of Youth and Sport is set aside and the 2-year ineligibility period imposed on Mr Yücel Kop is lifted.
2.) The decision with reference numbers 2008/54 and 2008/9 issued on 30 May 2008 by the Arbitral Tribunal of the Turkish General Directorate of Youth and Sport is set aside and a life-ban is imposed on Mrs Süreyya Ayhan Kop, commencing on the date of this award.
(…)
5.) All other motions or prayers for relief are dismissed.
